Boston Scientific receives CE Mark for agentTM drug-coated balloon
Boston Scientific has received CE Mark and begun the European market launch of the Agent™ Paclitaxel-Coated PTCA Balloon Catheter. The Agent Drug-Coated Balloon provides physicians with an additional alternative to treat both in-stent restenosis and de novo small vessel coronary disease. July 23, 2014